BNKL Stock Chart & Stats
$0.10
<$0.01(9900.00%)
At close: 4:00 PM EDT
$0.10
<$0.01(9900.00%)
Day’s Range― - ―
52-Week Range$0.10 - $0.10
Previous CloseN/A
Volume681.00
Average Volume (3M)0.00
Market Cap
$1.25K
Enterprise Value$1.99T
Total Cash (Recent Filing)$427.38K
Total Debt (Recent Filing)$2.41M
Price to Earnings (P/E)―
Beta1.37
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding12,480,263
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.68
Price to Sales (P/S)1.53
P/FCF Ratio-0.82
Enterprise Value/Market Cap1.59B
Enterprise Value/Revenue1.10M
Enterprise Value/Gross Profit2.01M
Enterprise Value/Ebitda-415.89K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BNKL FAQ
What was Bionik Laboratories Corp’s price range in the past 12 months?
Bionik Laboratories Corp lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Bionik Laboratories Corp’s market cap?
Bionik Laboratories Corp’s market cap is $1.25K.
When is Bionik Laboratories Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bionik Laboratories Corp’s earnings last quarter?
Bionik Laboratories Corp released its earnings results on Jun 28, 2023. The company reported -$0.195 earnings per share for the quarter.
Is Bionik Laboratories Corp overvalued?
According to Wall Street analysts Bionik Laboratories Corp’s price is currently Overvalued.
Does Bionik Laboratories Corp pay dividends?
Bionik Laboratories Corp does not currently pay dividends.
What is Bionik Laboratories Corp’s EPS estimate?
Bionik Laboratories Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bionik Laboratories Corp have?
Bionik Laboratories Corp has 12,480,263 shares outstanding.
What happened to Bionik Laboratories Corp’s price movement after its last earnings report?
Bionik Laboratories Corp reported an EPS of -$0.195 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bionik Laboratories Corp?
Currently, no hedge funds are holding shares in BNKL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bionik Laboratories Corp
Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.